Details for New Drug Application (NDA): 010124
✉ Email this page to a colleague
NDA 010124 describes SERPALAN, which is a drug marketed by Lannett and is included in one NDA. Additional details are available on the SERPALAN profile page.
The generic ingredient in SERPALAN is reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine profile page.
The generic ingredient in SERPALAN is reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine profile page.
Medical Subject Heading (MeSH) Categories for 010124
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.1MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
